Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Cancer Research|December 18, 2004
Protein kinase D2 mediates activation of nuclear factor kappaB by Bcr-Abl in Bcr-Abl+ human myeloid leukemia cellsTamara Mihailovic, Martin Marx, Alexandra Auer, et al.Current HIV Research|May 16, 2009
Increased red cell corpuscular volume and hepatic mitochondrial function in NRTI-treated HIV infected patientsThomas Sternfeld, Antje Lorenz, Mathias Schmid, et al.Experimental Hematology|March 31, 2004
CD30-induced up-regulation of the inhibitor of apoptosis genes cIAP1 and cIAP2 in anaplastic large cell lymphoma cellsGabriele Hübinger, Christof Schneider, Dagmar Stöhr, et al.Swiss Medical Weekly|November 10, 2017
Role of liver magnetic resonance imaging in hyperferritinaemia and the diagnosis of iron overloadAxel Ruefer, Christine Bapst, Rudolf Benz, et al.Therapeutic Advances in Rare Disease|May 14, 2023
Beyond pigmentation: signs of liver protection during afamelanotide treatment in Swiss patients with erythropoietic protoporphyria, an observational studyAnna-Elisabeth Minder, Jasmin Barman-Aksoezen, Mathias Schmid, et al.Cancer|December 3, 2005
The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all-trans retinoic acid in patients with acute myeloid leukemiaAndrea Kuendgen, Mathias Schmid, Richard Schlenk, et al.Epigenetics|June 17, 2016
Molecular dissection of valproic acid effects in acute myeloid leukemia identifies predictive networksFrank G Rücker, Katharina M Lang, Markus Fütterer, et al.Antiviral Therapy|August 24, 2007
The influence of HIV infection and antiretroviral therapy on the mitochondrial membrane potential of peripheral mononuclear cellsThomas Sternfeld, Mathias Schmid, Annette Tischleder, et al.Haematologica|March 16, 2012
Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromesNorbert Gattermann, Carlo Finelli, Matteo Della Porta, et al.Leukemia Research|May 11, 2010
Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC studyNorbert Gattermann, Carlo Finelli, Matteo Della Porta, et al.Pageof 3